AU2007295138B2 - Selective chemokine modulation - Google Patents

Selective chemokine modulation Download PDF

Info

Publication number
AU2007295138B2
AU2007295138B2 AU2007295138A AU2007295138A AU2007295138B2 AU 2007295138 B2 AU2007295138 B2 AU 2007295138B2 AU 2007295138 A AU2007295138 A AU 2007295138A AU 2007295138 A AU2007295138 A AU 2007295138A AU 2007295138 B2 AU2007295138 B2 AU 2007295138B2
Authority
AU
Australia
Prior art keywords
metal
oxide
titanium
group
fluid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2007295138A
Other languages
English (en)
Other versions
AU2007295138A1 (en
Inventor
Lars Bruce
Staale Petter Lyngstadaas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PROPHY MED AB
Original Assignee
PROPHY MED AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39184028&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2007295138(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by PROPHY MED AB filed Critical PROPHY MED AB
Publication of AU2007295138A1 publication Critical patent/AU2007295138A1/en
Application granted granted Critical
Publication of AU2007295138B2 publication Critical patent/AU2007295138B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3679—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by absorption
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/38—Removing constituents from donor blood and storing or returning remainder to body, e.g. for transfusion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/02—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/02—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material
    • B01J20/06—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material comprising oxides or hydroxides of metals not provided for in group B01J20/04
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Virology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
AU2007295138A 2006-09-12 2007-09-11 Selective chemokine modulation Ceased AU2007295138B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US84376006P 2006-09-12 2006-09-12
US60/843,760 2006-09-12
PCT/SE2007/000785 WO2008033069A1 (en) 2006-09-12 2007-09-11 Selective chemokine modulation

Publications (2)

Publication Number Publication Date
AU2007295138A1 AU2007295138A1 (en) 2008-03-20
AU2007295138B2 true AU2007295138B2 (en) 2012-10-04

Family

ID=39184028

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2007295138A Ceased AU2007295138B2 (en) 2006-09-12 2007-09-11 Selective chemokine modulation

Country Status (17)

Country Link
US (3) US8784845B2 (cg-RX-API-DMAC10.html)
EP (1) EP2068895B1 (cg-RX-API-DMAC10.html)
JP (1) JP5290179B2 (cg-RX-API-DMAC10.html)
KR (1) KR101419963B1 (cg-RX-API-DMAC10.html)
CN (1) CN101573126B (cg-RX-API-DMAC10.html)
AU (1) AU2007295138B2 (cg-RX-API-DMAC10.html)
BR (1) BRPI0716728A2 (cg-RX-API-DMAC10.html)
CA (1) CA2663259C (cg-RX-API-DMAC10.html)
ES (1) ES2401031T3 (cg-RX-API-DMAC10.html)
IL (1) IL197562A (cg-RX-API-DMAC10.html)
MX (1) MX2009002699A (cg-RX-API-DMAC10.html)
MY (1) MY148756A (cg-RX-API-DMAC10.html)
NO (1) NO341876B1 (cg-RX-API-DMAC10.html)
NZ (1) NZ576190A (cg-RX-API-DMAC10.html)
RU (1) RU2446809C2 (cg-RX-API-DMAC10.html)
SG (1) SG174094A1 (cg-RX-API-DMAC10.html)
WO (1) WO2008033069A1 (cg-RX-API-DMAC10.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE531319C2 (sv) 2007-02-22 2009-02-24 Tigran Technologies Ab Publ Porös implantatgranul
US9957311B2 (en) 2013-12-20 2018-05-01 Tikomed Ab Surface-binding peptide
CN104020297B (zh) * 2014-06-10 2016-12-07 上海交通大学医学院 用于结核分枝杆菌感染检测及临床治疗效果监测的试剂盒及其用途
JP6631499B2 (ja) * 2016-12-27 2020-01-15 トヨタ自動車株式会社 ハイブリッド車両の制御装置
CA3183415A1 (en) 2020-05-11 2021-11-18 Minnetronix Neuro, Inc. Filtering cassettes and filtering systems

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0686848A1 (en) * 1994-05-09 1995-12-13 Shiseido Company Limited Liquid chromatograph having a micro and semi-micro column
US6527951B1 (en) * 2000-11-16 2003-03-04 Waters Investments Limited Chromatographic column
US20030055106A1 (en) * 1999-08-12 2003-03-20 Robert Faure Therapeutic uses of peroxometallic compounds
WO2006055675A1 (en) * 2004-11-16 2006-05-26 Waters Investments Limited Device for performing separations and methods of making and using same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2252729B (en) 1991-02-13 1994-11-09 Bharat Sridhar Pancham Vitamin and/or mineral containing pharmaceutical compositions
CA2280249A1 (en) * 1999-08-12 2001-02-12 Universite Laval Vanadium compounds as anti-angiogenics and as inhibitors of endothelin production
DE19938668B4 (de) * 1999-08-14 2006-01-26 Bausch & Lomb Inc. Tränenersatzmittel
US20050119105A1 (en) * 2002-01-18 2005-06-02 Schott Ag Glass-ceramic composite containing nanoparticles
DE10201747C1 (de) 2002-01-18 2003-08-14 Schott Glas Glas-Keramik-Komposit, Verfahren zu seiner Herstellung und Verwendungen

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0686848A1 (en) * 1994-05-09 1995-12-13 Shiseido Company Limited Liquid chromatograph having a micro and semi-micro column
US20030055106A1 (en) * 1999-08-12 2003-03-20 Robert Faure Therapeutic uses of peroxometallic compounds
US6527951B1 (en) * 2000-11-16 2003-03-04 Waters Investments Limited Chromatographic column
WO2006055675A1 (en) * 2004-11-16 2006-05-26 Waters Investments Limited Device for performing separations and methods of making and using same

Also Published As

Publication number Publication date
CN101573126B (zh) 2012-04-25
EP2068895A4 (en) 2009-12-23
EP2068895A1 (en) 2009-06-17
SG174094A1 (en) 2011-09-29
US9649426B2 (en) 2017-05-16
KR101419963B1 (ko) 2014-07-30
RU2009113579A (ru) 2010-10-20
RU2446809C2 (ru) 2012-04-10
CN101573126A (zh) 2009-11-04
US8784845B2 (en) 2014-07-22
WO2008033069A1 (en) 2008-03-20
US20100203089A1 (en) 2010-08-12
NZ576190A (en) 2011-06-30
NO20091420L (no) 2009-06-11
JP2010503666A (ja) 2010-02-04
AU2007295138A1 (en) 2008-03-20
IL197562A (en) 2013-12-31
BRPI0716728A2 (pt) 2017-06-13
US20140302149A1 (en) 2014-10-09
NO341876B1 (no) 2018-02-12
WO2008033069A8 (en) 2009-07-23
CA2663259A1 (en) 2008-03-20
US9656015B2 (en) 2017-05-23
KR20090069293A (ko) 2009-06-30
US20140299548A1 (en) 2014-10-09
MY148756A (en) 2013-05-31
ES2401031T3 (es) 2013-04-16
IL197562A0 (en) 2009-12-24
JP5290179B2 (ja) 2013-09-18
CA2663259C (en) 2017-01-03
EP2068895B1 (en) 2012-12-12
MX2009002699A (es) 2009-06-11

Similar Documents

Publication Publication Date Title
Yang et al. Neutrophils in tissue injury and repair: molecular mechanisms and therapeutic targets
Wang et al. Cellular nanosponges for biological neutralization
US9649426B2 (en) Selective chemokine modulation
EP2970381A2 (en) Methods for making cytokine compositions from tissues using non-centrifugal methods
WO2011068897A9 (en) Method for removing cytokines from blood with surface immobilized polysaccharides
JP2009525297A5 (cg-RX-API-DMAC10.html)
CN114099481B (zh) 雾化吸入型糖皮质激素纳米药物及其制备方法和应用
WO2022150839A1 (en) Immune modulation by mesenchymal stem cells
US20220395540A1 (en) Treatment of covid-19 lung injury using umbilical cord plasma based compositions
JP2006525238A (ja) 活性炭輸液剤、その調製方法及び癌治療用薬物の調製におけるその使用
Alrashedi et al. Detection of Association Between Some of Nanoparticles (Zn, Ag) and Rheumatoid Arthritis in Rats
EP1618884A1 (en) Instrument for inducing cytokine and method of inducing cytokine
CN121041458A (zh) 一种纳豆激酶制剂在制备预防或治疗脓毒症的药物中的用途
Matsui Leukocyte removal therapy before surgery in ulcerative colitis
CN111803525A (zh) 人羊膜上皮细胞在制备预防或治疗老年衰弱症药物中的用途
CN110812362A (zh) 腺嘌呤在制备治疗β地中海贫血的药物中的应用
CN112043689A (zh) 一种用于抑制脂多糖诱导巨噬细胞炎症的药物组合物及其应用
Muñoz et al. Adsorptive monocyte and granulocyte apheresis in the chronic inflammatory illness: ulcerous colitis, Crohn's disease, rheumatoid arthritis and Behcet syndrome
JP2004323483A (ja) 炎症性疾患治療剤及び炎症性疾患治療用具
HK1230116B (en) Method for removing cytokines from blood with surface immobilized polysaccharides

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired